Parametric Portfolio Associates’s Atara Biotherapeutics ATRA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $295K | Sell |
1,269
-951
| -43% | -$221K | ﹤0.01% | 3286 |
|
|
2021
Q4 | $875K | Buy |
2,220
+326
| +17% | +$128K | ﹤0.01% | 2838 |
|
|
2021
Q3 | $848K | Sell |
1,894
-427
| -18% | -$191K | ﹤0.01% | 2872 |
|
|
2021
Q2 | $902K | Sell |
2,321
-275
| -11% | -$107K | ﹤0.01% | 2814 |
|
|
2021
Q1 | $932K | Buy |
2,596
+608
| +31% | +$218K | ﹤0.01% | 3195 |
|
|
2020
Q4 | $976K | Buy |
1,988
+238
| +14% | +$117K | ﹤0.01% | 3067 |
|
|
2020
Q3 | $567K | Buy |
1,750
+264
| +18% | +$85.5K | ﹤0.01% | 3210 |
|
|
2020
Q2 | $541K | Buy |
1,486
+193
| +15% | +$70.3K | ﹤0.01% | 3233 |
|
|
2020
Q1 | $275K | Sell |
1,293
-67
| -5% | -$14.3K | ﹤0.01% | 3426 |
|
|
2019
Q4 | $560K | Buy |
1,360
+285
| +27% | +$117K | ﹤0.01% | 3328 |
|
|
2019
Q3 | $380K | Buy |
+1,075
| New | +$380K | ﹤0.01% | 3439 |
|
|
2019
Q2 | – | Sell |
-384
| Closed | -$382K | – | 3958 |
|
|
2019
Q1 | $382K | Sell |
384
-705
| -65% | -$701K | ﹤0.01% | 3459 |
|
|
2018
Q4 | $945K | Sell |
1,089
-22
| -2% | -$19.1K | ﹤0.01% | 3014 |
|
|
2018
Q3 | $1.15M | Sell |
1,111
-1
| -0.1% | -$1.03K | ﹤0.01% | 3013 |
|
|
2018
Q2 | $1.02M | Buy |
1,112
+27
| +2% | +$24.8K | ﹤0.01% | 3047 |
|
|
2018
Q1 | $1.06M | Sell |
1,085
-627
| -37% | -$611K | ﹤0.01% | 2983 |
|
|
2017
Q4 | $775K | Buy |
1,712
+474
| +38% | +$215K | ﹤0.01% | 3137 |
|
|
2017
Q3 | $512K | Buy |
1,238
+51
| +4% | +$21.1K | ﹤0.01% | 3409 |
|
|
2017
Q2 | $415K | Buy |
1,187
+171
| +17% | +$59.8K | ﹤0.01% | 3469 |
|
|
2017
Q1 | $522K | Buy |
1,016
+391
| +63% | +$201K | ﹤0.01% | 3185 |
|
|
2016
Q4 | $222K | Sell |
625
-88
| -12% | -$31.3K | ﹤0.01% | 3551 |
|
|
2016
Q3 | $381K | Buy |
713
+84
| +13% | +$44.9K | ﹤0.01% | 3302 |
|
|
2016
Q2 | $354K | Buy |
+629
| New | +$354K | ﹤0.01% | 3376 |
|